Stargardt Disease clinical trials at UCSD

1 research study open to eligible people

Tinlarebant in Subjects With Stargardt Disease
open to eligible people ages 12-20
The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease
La Jolla, California and other locations

Last updated: June 19, 2025